Published in Sci Rep on January 11, 2017
MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 198.59
Cancer statistics, 2014. CA Cancer J Clin (2014) 72.81
The functions of animal microRNAs. Nature (2004) 64.85
Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem (2004) 14.93
MicroRNAs in Cancer. Annu Rev Med (2009) 9.37
Multidisciplinary management of lung cancer. N Engl J Med (2004) 7.13
MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell (2008) 5.34
Translational control of p27Kip1 accumulation during the cell cycle. Science (1996) 5.04
Replication protein A (RPA): the eukaryotic SSB. Crit Rev Biochem Mol Biol (1999) 3.85
DNA repair in eukaryotes. Annu Rev Biochem (1996) 3.82
Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data from 16 randomized controlled trials. J Clin Oncol (2008) 3.03
The comings and goings of nucleotide excision repair factors on damaged DNA. EMBO J (2003) 2.89
Complex formation by all five homologues of mammalian translation initiation factor 3 subunits from yeast Saccharomyces cerevisiae. J Biol Chem (1998) 2.53
Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection. Cancer Res (2009) 2.50
Regulation of DNA replication by ATR: signaling in response to DNA intermediates. DNA Repair (Amst) (2004) 2.05
A pathway in quiescent cells that controls p27Kip1 stability, subcellular localization, and tumor suppression. Genes Dev (2006) 2.05
Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy. J Clin Invest (1994) 1.97
Purification and characterization of initiation factor IF-E3 from rabbit reticulocytes. Proc Natl Acad Sci U S A (1976) 1.73
Structural characterization of the human eukaryotic initiation factor 3 protein complex by mass spectrometry. Mol Cell Proteomics (2007) 1.71
Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD/ERCC2 genotypes. Carcinogenesis (2002) 1.52
Initiation factor eIF3 and regulation of mRNA translation, cell growth, and cancer. Crit Rev Oncol Hematol (2006) 1.42
Role of eIF3 p170 in controlling synthesis of ribonucleotide reductase M2 and cell growth. Oncogene (2004) 1.36
Protein interactions and complexes in human microRNA biogenesis and function. Front Biosci (2008) 1.33
The human homologue of the yeast Prt1 protein is an integral part of the eukaryotic initiation factor 3 complex and interacts with p170. J Biol Chem (1997) 1.29
EIF3 p170, a mediator of mimosine effect on protein synthesis and cell cycle progression. Mol Biol Cell (2003) 1.21
Development of a high-throughput screen for inhibitors of replication protein A and its role in nucleotide excision repair. Mol Cancer Ther (2004) 1.20
miR 488* inhibits androgen receptor expression in prostate carcinoma cells. Int J Cancer (2011) 1.19
Identification of a 170-kDa protein over-expressed in lung cancers. Br J Cancer (2001) 1.17
Characterization of cDNAs encoding the p44 and p35 subunits of human translation initiation factor eIF3. J Biol Chem (1998) 1.17
Role of eIF3a in regulating cell cycle progression. Exp Cell Res (2009) 1.14
Expression of p150 in cervical neoplasia and its potential value in predicting survival. Cancer (1998) 1.11
p150 expression and its prognostic value in squamous-cell carcinoma of the esophagus. Int J Cancer (1999) 1.08
Effect of eIF3a on response of lung cancer patients to platinum-based chemotherapy by regulating DNA repair. Clin Cancer Res (2011) 1.08
Cloning of a novel protein overexpressed in human mammary carcinoma. Cancer Res (1997) 1.06
Role of eIF3a (eIF3 p170) in intestinal cell differentiation and its association with early development. Differentiation (2007) 1.00
Cyclin D2 translocates p27 out of the nucleus and promotes its degradation at the G0-G1 transition. Mol Cell Biol (2007) 0.95
Translational regulation of RPA2 via internal ribosomal entry site and by eIF3a. Carcinogenesis (2013) 0.95
Decreased miRNA-637 is an unfavorable prognosis marker and promotes glioma cell growth, migration and invasion via direct targeting Akt1. Oncogene (2015) 0.94
The involvement of XPC protein in the cisplatin DNA damaging treatment-mediated cellular response. Cell Res (2004) 0.91
The A/G allele of eIF3a rs3740556 predicts platinum-based chemotherapy resistance in lung cancer patients. Lung Cancer (2012) 0.88
MicroRNA-488 regulates zinc transporter SLC39A8/ZIP8 during pathogenesis of osteoarthritis. J Biomed Sci (2013) 0.88
Evidence for direct contact between the RPA3 subunit of the human replication protein A and single-stranded DNA. Nucleic Acids Res (2008) 0.86
Association between eIF3α polymorphism and severe toxicity caused by platinum-based chemotherapy in non-small cell lung cancer patients. Br J Clin Pharmacol (2013) 0.85
miR-29b Mediates NF-κB Signaling in KRAS-Induced Non-Small Cell Lung Cancers. Cancer Res (2016) 0.84
The prognostic value of altered eIF3a and its association with p27 in non-small cell lung cancers. PLoS One (2014) 0.84
eIF3a improve cisplatin sensitivity in ovarian cancer by regulating XPC and p27Kip1 translation. Oncotarget (2015) 0.83
The role of microRNA in metastatic processes of non-small cell lung carcinoma. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub (2016) 0.83
Early Events in the Molecular Pathogenesis of Lung Cancer. Cancer Prev Res (Phila) (2016) 0.80
Eukaryotic translation initiation factor 3, subunit a, regulates the extracellular signal-regulated kinase pathway. Mol Cell Biol (2011) 0.80
Pharmacogenetics of conventional chemotherapy in non-small-cell lung cancer: a changing landscape? Pharmacogenomics (2012) 0.80
Safety profiles of first-line therapies for metastatic non-squamous non-small-cell lung cancer. Expert Opin Drug Saf (2016) 0.79
miR-488 acts as a tumor suppressor gene in gastric cancer. Tumour Biol (2016) 0.79
Research progress in cancer stem cells and their drug resistance. Chin J Cancer (2010) 0.79
MicroRNA-488 suppresses cell migration through modulation of the focal adhesion activity during chondrogenic differentiation of chick limb mesenchymal cells. Cell Biol Int (2011) 0.78
Expression of miRNA-26b in the diagnosis and prognosis of patients with non-small-cell lung cancer. Future Oncol (2016) 0.77